Global Liposomes Market Growth 2025-2031

October 2025 | 122 pages | ID: G956D885A5FDEN
LP Information

Abstracts

The global Liposomes market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Liposomes are spherical nano-sized bilayered vesicles or ?bags? in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer.

North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.

LP Information, Inc. (LPI) ' newest research report, the ?Liposomes Industry Forecast? looks at past sales and reviews total world Liposomes sales in 2024, providing a comprehensive analysis by region and market sector of projected Liposomes sales for 2025 through 2031. With Liposomes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposomes industry.

This Insight Report provides a comprehensive analysis of the global Liposomes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposomes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Liposomes market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposomes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposomes.

This report presents a comprehensive overview, market shares, and growth opportunities of Liposomes market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Liposomal Doxorubicin
• Liposomal Amphoteracin B
• Liposomal Paclitaxel
• Others

Segmentation by Application:

• Fungal Infection Therapy
• Cancer & Tumor Therapy
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Johnson & Johnson
• Gilead Sciences
• Pacira
• Sun Pharmaceutical
• Luye Pharma
• Sigma-Tau Group
• Fudan-Zhangjiang
• Teva Pharmaceutical
• CSPC
• Novartis
• Kingond Pharm
• Spectrum Pharmaceuticals
• Shanghai New Asia

Key Questions Addressed in this Report

What is the 10-year outlook for the global Liposomes market?
What factors are driving Liposomes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liposomes market opportunities vary by end market size?
How does Liposomes break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Liposomes Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Liposomes by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Liposomes by Country/Region, 2020, 2024 & 2031
2.2 Liposomes Segment by Type
  2.2.1 Liposomal Doxorubicin
  2.2.2 Liposomal Amphoteracin B
  2.2.3 Liposomal Paclitaxel
  2.2.4 Others
2.3 Liposomes Sales by Type
  2.3.1 Global Liposomes Sales Market Share by Type (2020-2025)
  2.3.2 Global Liposomes Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Liposomes Sale Price by Type (2020-2025)
2.4 Liposomes Segment by Application
  2.4.1 Fungal Infection Therapy
  2.4.2 Cancer & Tumor Therapy
  2.4.3 Others
2.5 Liposomes Sales by Application
  2.5.1 Global Liposomes Sale Market Share by Application (2020-2025)
  2.5.2 Global Liposomes Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Liposomes Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Liposomes Breakdown Data by Company
  3.1.1 Global Liposomes Annual Sales by Company (2020-2025)
  3.1.2 Global Liposomes Sales Market Share by Company (2020-2025)
3.2 Global Liposomes Annual Revenue by Company (2020-2025)
  3.2.1 Global Liposomes Revenue by Company (2020-2025)
  3.2.2 Global Liposomes Revenue Market Share by Company (2020-2025)
3.3 Global Liposomes Sale Price by Company
3.4 Key Manufacturers Liposomes Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Liposomes Product Location Distribution
  3.4.2 Players Liposomes Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR LIPOSOMES BY GEOGRAPHIC REGION

4.1 World Historic Liposomes Market Size by Geographic Region (2020-2025)
  4.1.1 Global Liposomes Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Liposomes Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Liposomes Market Size by Country/Region (2020-2025)
  4.2.1 Global Liposomes Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Liposomes Annual Revenue by Country/Region (2020-2025)
4.3 Americas Liposomes Sales Growth
4.4 APAC Liposomes Sales Growth
4.5 Europe Liposomes Sales Growth
4.6 Middle East & Africa Liposomes Sales Growth

5 AMERICAS

5.1 Americas Liposomes Sales by Country
  5.1.1 Americas Liposomes Sales by Country (2020-2025)
  5.1.2 Americas Liposomes Revenue by Country (2020-2025)
5.2 Americas Liposomes Sales by Type (2020-2025)
5.3 Americas Liposomes Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Liposomes Sales by Region
  6.1.1 APAC Liposomes Sales by Region (2020-2025)
  6.1.2 APAC Liposomes Revenue by Region (2020-2025)
6.2 APAC Liposomes Sales by Type (2020-2025)
6.3 APAC Liposomes Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Liposomes by Country
  7.1.1 Europe Liposomes Sales by Country (2020-2025)
  7.1.2 Europe Liposomes Revenue by Country (2020-2025)
7.2 Europe Liposomes Sales by Type (2020-2025)
7.3 Europe Liposomes Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Liposomes by Country
  8.1.1 Middle East & Africa Liposomes Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Liposomes Revenue by Country (2020-2025)
8.2 Middle East & Africa Liposomes Sales by Type (2020-2025)
8.3 Middle East & Africa Liposomes Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposomes
10.3 Manufacturing Process Analysis of Liposomes
10.4 Industry Chain Structure of Liposomes

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Liposomes Distributors
11.3 Liposomes Customer

12 WORLD FORECAST REVIEW FOR LIPOSOMES BY GEOGRAPHIC REGION

12.1 Global Liposomes Market Size Forecast by Region
  12.1.1 Global Liposomes Forecast by Region (2026-2031)
  12.1.2 Global Liposomes Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Liposomes Forecast by Type (2026-2031)
12.7 Global Liposomes Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Information
  13.1.2 Johnson & Johnson Liposomes Product Portfolios and Specifications
  13.1.3 Johnson & Johnson Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Johnson & Johnson Main Business Overview
  13.1.5 Johnson & Johnson Latest Developments
13.2 Gilead Sciences
  13.2.1 Gilead Sciences Company Information
  13.2.2 Gilead Sciences Liposomes Product Portfolios and Specifications
  13.2.3 Gilead Sciences Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Gilead Sciences Main Business Overview
  13.2.5 Gilead Sciences Latest Developments
13.3 Pacira
  13.3.1 Pacira Company Information
  13.3.2 Pacira Liposomes Product Portfolios and Specifications
  13.3.3 Pacira Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Pacira Main Business Overview
  13.3.5 Pacira Latest Developments
13.4 Sun Pharmaceutical
  13.4.1 Sun Pharmaceutical Company Information
  13.4.2 Sun Pharmaceutical Liposomes Product Portfolios and Specifications
  13.4.3 Sun Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Sun Pharmaceutical Main Business Overview
  13.4.5 Sun Pharmaceutical Latest Developments
13.5 Luye Pharma
  13.5.1 Luye Pharma Company Information
  13.5.2 Luye Pharma Liposomes Product Portfolios and Specifications
  13.5.3 Luye Pharma Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Luye Pharma Main Business Overview
  13.5.5 Luye Pharma Latest Developments
13.6 Sigma-Tau Group
  13.6.1 Sigma-Tau Group Company Information
  13.6.2 Sigma-Tau Group Liposomes Product Portfolios and Specifications
  13.6.3 Sigma-Tau Group Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Sigma-Tau Group Main Business Overview
  13.6.5 Sigma-Tau Group Latest Developments
13.7 Fudan-Zhangjiang
  13.7.1 Fudan-Zhangjiang Company Information
  13.7.2 Fudan-Zhangjiang Liposomes Product Portfolios and Specifications
  13.7.3 Fudan-Zhangjiang Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Fudan-Zhangjiang Main Business Overview
  13.7.5 Fudan-Zhangjiang Latest Developments
13.8 Teva Pharmaceutical
  13.8.1 Teva Pharmaceutical Company Information
  13.8.2 Teva Pharmaceutical Liposomes Product Portfolios and Specifications
  13.8.3 Teva Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Teva Pharmaceutical Main Business Overview
  13.8.5 Teva Pharmaceutical Latest Developments
13.9 CSPC
  13.9.1 CSPC Company Information
  13.9.2 CSPC Liposomes Product Portfolios and Specifications
  13.9.3 CSPC Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 CSPC Main Business Overview
  13.9.5 CSPC Latest Developments
13.10 Novartis
  13.10.1 Novartis Company Information
  13.10.2 Novartis Liposomes Product Portfolios and Specifications
  13.10.3 Novartis Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Novartis Main Business Overview
  13.10.5 Novartis Latest Developments
13.11 Kingond Pharm
  13.11.1 Kingond Pharm Company Information
  13.11.2 Kingond Pharm Liposomes Product Portfolios and Specifications
  13.11.3 Kingond Pharm Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Kingond Pharm Main Business Overview
  13.11.5 Kingond Pharm Latest Developments
13.12 Spectrum Pharmaceuticals
  13.12.1 Spectrum Pharmaceuticals Company Information
  13.12.2 Spectrum Pharmaceuticals Liposomes Product Portfolios and Specifications
  13.12.3 Spectrum Pharmaceuticals Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Spectrum Pharmaceuticals Main Business Overview
  13.12.5 Spectrum Pharmaceuticals Latest Developments
13.13 Shanghai New Asia
  13.13.1 Shanghai New Asia Company Information
  13.13.2 Shanghai New Asia Liposomes Product Portfolios and Specifications
  13.13.3 Shanghai New Asia Liposomes Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Shanghai New Asia Main Business Overview
  13.13.5 Shanghai New Asia Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Liposomes Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Liposomes Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liposomal Doxorubicin
Table 4. Major Players of Liposomal Amphoteracin B
Table 5. Major Players of Liposomal Paclitaxel
Table 6. Major Players of Others
Table 7. Global Liposomes Sales by Type (2020-2025) & (K Units)
Table 8. Global Liposomes Sales Market Share by Type (2020-2025)
Table 9. Global Liposomes Revenue by Type (2020-2025) & ($ million)
Table 10. Global Liposomes Revenue Market Share by Type (2020-2025)
Table 11. Global Liposomes Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Liposomes Sale by Application (2020-2025) & (K Units)
Table 13. Global Liposomes Sale Market Share by Application (2020-2025)
Table 14. Global Liposomes Revenue by Application (2020-2025) & ($ million)
Table 15. Global Liposomes Revenue Market Share by Application (2020-2025)
Table 16. Global Liposomes Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Liposomes Sales by Company (2020-2025) & (K Units)
Table 18. Global Liposomes Sales Market Share by Company (2020-2025)
Table 19. Global Liposomes Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Liposomes Revenue Market Share by Company (2020-2025)
Table 21. Global Liposomes Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Liposomes Producing Area Distribution and Sales Area
Table 23. Players Liposomes Products Offered
Table 24. Liposomes Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Liposomes Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Liposomes Sales Market Share Geographic Region (2020-2025)
Table 29. Global Liposomes Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Liposomes Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Liposomes Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Liposomes Sales Market Share by Country/Region (2020-2025)
Table 33. Global Liposomes Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Liposomes Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Liposomes Sales by Country (2020-2025) & (K Units)
Table 36. Americas Liposomes Sales Market Share by Country (2020-2025)
Table 37. Americas Liposomes Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Liposomes Sales by Type (2020-2025) & (K Units)
Table 39. Americas Liposomes Sales by Application (2020-2025) & (K Units)
Table 40. APAC Liposomes Sales by Region (2020-2025) & (K Units)
Table 41. APAC Liposomes Sales Market Share by Region (2020-2025)
Table 42. APAC Liposomes Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Liposomes Sales by Type (2020-2025) & (K Units)
Table 44. APAC Liposomes Sales by Application (2020-2025) & (K Units)
Table 45. Europe Liposomes Sales by Country (2020-2025) & (K Units)
Table 46. Europe Liposomes Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Liposomes Sales by Type (2020-2025) & (K Units)
Table 48. Europe Liposomes Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Liposomes Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Liposomes Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Liposomes Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Liposomes Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Liposomes
Table 54. Key Market Challenges & Risks of Liposomes
Table 55. Key Industry Trends of Liposomes
Table 56. Liposomes Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Liposomes Distributors List
Table 59. Liposomes Customer List
Table 60. Global Liposomes Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Liposomes Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Liposomes Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Liposomes Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Liposomes Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Liposomes Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Liposomes Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Liposomes Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Liposomes Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Liposomes Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Liposomes Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Liposomes Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Liposomes Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Liposomes Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Johnson & Johnson Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 75. Johnson & Johnson Liposomes Product Portfolios and Specifications
Table 76. Johnson & Johnson Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Latest Developments
Table 79. Gilead Sciences Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 80. Gilead Sciences Liposomes Product Portfolios and Specifications
Table 81. Gilead Sciences Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Gilead Sciences Main Business
Table 83. Gilead Sciences Latest Developments
Table 84. Pacira Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 85. Pacira Liposomes Product Portfolios and Specifications
Table 86. Pacira Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Pacira Main Business
Table 88. Pacira Latest Developments
Table 89. Sun Pharmaceutical Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 90. Sun Pharmaceutical Liposomes Product Portfolios and Specifications
Table 91. Sun Pharmaceutical Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Sun Pharmaceutical Main Business
Table 93. Sun Pharmaceutical Latest Developments
Table 94. Luye Pharma Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 95. Luye Pharma Liposomes Product Portfolios and Specifications
Table 96. Luye Pharma Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Luye Pharma Main Business
Table 98. Luye Pharma Latest Developments
Table 99. Sigma-Tau Group Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 100. Sigma-Tau Group Liposomes Product Portfolios and Specifications
Table 101. Sigma-Tau Group Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Sigma-Tau Group Main Business
Table 103. Sigma-Tau Group Latest Developments
Table 104. Fudan-Zhangjiang Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 105. Fudan-Zhangjiang Liposomes Product Portfolios and Specifications
Table 106. Fudan-Zhangjiang Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Fudan-Zhangjiang Main Business
Table 108. Fudan-Zhangjiang Latest Developments
Table 109. Teva Pharmaceutical Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 110. Teva Pharmaceutical Liposomes Product Portfolios and Specifications
Table 111. Teva Pharmaceutical Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Teva Pharmaceutical Main Business
Table 113. Teva Pharmaceutical Latest Developments
Table 114. CSPC Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 115. CSPC Liposomes Product Portfolios and Specifications
Table 116. CSPC Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. CSPC Main Business
Table 118. CSPC Latest Developments
Table 119. Novartis Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis Liposomes Product Portfolios and Specifications
Table 121. Novartis Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Novartis Main Business
Table 123. Novartis Latest Developments
Table 124. Kingond Pharm Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 125. Kingond Pharm Liposomes Product Portfolios and Specifications
Table 126. Kingond Pharm Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Kingond Pharm Main Business
Table 128. Kingond Pharm Latest Developments
Table 129. Spectrum Pharmaceuticals Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 130. Spectrum Pharmaceuticals Liposomes Product Portfolios and Specifications
Table 131. Spectrum Pharmaceuticals Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Spectrum Pharmaceuticals Main Business
Table 133. Spectrum Pharmaceuticals Latest Developments
Table 134. Shanghai New Asia Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 135. Shanghai New Asia Liposomes Product Portfolios and Specifications
Table 136. Shanghai New Asia Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Shanghai New Asia Main Business
Table 138. Shanghai New Asia Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Liposomes
Figure 2. Liposomes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liposomes Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Liposomes Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Liposomes Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Liposomes Sales Market Share by Country/Region (2024)
Figure 10. Liposomes Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liposomal Doxorubicin
Figure 12. Product Picture of Liposomal Amphoteracin B
Figure 13. Product Picture of Liposomal Paclitaxel
Figure 14. Product Picture of Others
Figure 15. Global Liposomes Sales Market Share by Type in 2025
Figure 16. Global Liposomes Revenue Market Share by Type (2020-2025)
Figure 17. Liposomes Consumed in Fungal Infection Therapy
Figure 18. Global Liposomes Market: Fungal Infection Therapy (2020-2025) & (K Units)
Figure 19. Liposomes Consumed in Cancer & Tumor Therapy
Figure 20. Global Liposomes Market: Cancer & Tumor Therapy (2020-2025) & (K Units)
Figure 21. Liposomes Consumed in Others
Figure 22. Global Liposomes Market: Others (2020-2025) & (K Units)
Figure 23. Global Liposomes Sale Market Share by Application (2024)
Figure 24. Global Liposomes Revenue Market Share by Application in 2025
Figure 25. Liposomes Sales by Company in 2025 (K Units)
Figure 26. Global Liposomes Sales Market Share by Company in 2025
Figure 27. Liposomes Revenue by Company in 2025 ($ millions)
Figure 28. Global Liposomes Revenue Market Share by Company in 2025
Figure 29. Global Liposomes Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Liposomes Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Liposomes Sales 2020-2025 (K Units)
Figure 32. Americas Liposomes Revenue 2020-2025 ($ millions)
Figure 33. APAC Liposomes Sales 2020-2025 (K Units)
Figure 34. APAC Liposomes Revenue 2020-2025 ($ millions)
Figure 35. Europe Liposomes Sales 2020-2025 (K Units)
Figure 36. Europe Liposomes Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Liposomes Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Liposomes Revenue 2020-2025 ($ millions)
Figure 39. Americas Liposomes Sales Market Share by Country in 2025
Figure 40. Americas Liposomes Revenue Market Share by Country (2020-2025)
Figure 41. Americas Liposomes Sales Market Share by Type (2020-2025)
Figure 42. Americas Liposomes Sales Market Share by Application (2020-2025)
Figure 43. United States Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Liposomes Sales Market Share by Region in 2025
Figure 48. APAC Liposomes Revenue Market Share by Region (2020-2025)
Figure 49. APAC Liposomes Sales Market Share by Type (2020-2025)
Figure 50. APAC Liposomes Sales Market Share by Application (2020-2025)
Figure 51. China Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 55. India Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Liposomes Sales Market Share by Country in 2025
Figure 59. Europe Liposomes Revenue Market Share by Country (2020-2025)
Figure 60. Europe Liposomes Sales Market Share by Type (2020-2025)
Figure 61. Europe Liposomes Sales Market Share by Application (2020-2025)
Figure 62. Germany Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 63. France Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Liposomes Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Liposomes Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Liposomes Sales Market Share by Application (2020-2025)
Figure 70. Egypt Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Liposomes Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Liposomes in 2025
Figure 76. Manufacturing Process Analysis of Liposomes
Figure 77. Industry Chain Structure of Liposomes
Figure 78. Channels of Distribution
Figure 79. Global Liposomes Sales Market Forecast by Region (2026-2031)
Figure 80. Global Liposomes Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Liposomes Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Liposomes Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Liposomes Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Liposomes Revenue Market Share Forecast by Application (2026-2031)